Dr Shudong Wang
Expert and
Reader of kinase inhibitor
and new drugs, University of
Nottingham, UK
Dr Shudong
Wang is an Associate
Professor and Reader in the
School of Pharmacy,
University of Nottingham,
UK. Prior to join the
university in October 2005,
she worked for Cyclacel
Ltd., a biopharmaceutical
company in Scotland,
initially as a medicinal
chemist and then Head of
Chemistry in 2000. She
helped to establish
medicinal chemistry and drug
discovery capabilities of
the company. From 2000-2005,
as a program manager she was
also involved in research
and management of an
oncology drug discovery
program. She led a
multi-disciplinary team and
successfully delivered
several credible drug leads,
some of which are currently
at clinical and pre-clinical
development stages. Dr Wang
obtained her PhD from the
Center for Molecular
Architecture, Central
Queensland University,
Australia in 1997.
Dr Wang’s
current research focuses on
the discovery and
development of novel protein
kinase inhibitors for
various therapeutic
indications. This involves
structure- and target-guided
design and synthesis of
compound libraries that are
used to characterise the
cellular consequences
associated with the
diseases. The strategy holds
promise for rapid
advancement of drug
discovery in an effort to
identify both drug
candidates and novel
therapeutic targets.
Dr Wang has
trained many researchers at
all levels from
undergraduate project
students, PhD students and
post doctors. Since joining
the School in October 2005
her group has grown with 7
PhD students and 4 post
doctoral researchers. She is
a Guest Professor at Sun
Yat-Sen University, China
and a Fellow of The Royal
Society of Chemistry and a
member of Young Chemists
Committee, America
Association of Cancer
Research, American Chemical
Society, and The Royal
Australia Chemical Society.
To date she has authored
over 90 research papers and
patents. Further details of
Dr Wang’s research can be
found on
http://www.nottingham.ac.uk/pharmacy/stafflookup/staff-list.php?id=ODA1OTky&page_var=personal